PATRYS LIMITED - Announcements

Market Cap $16.46M Add to my watchlist

Healthcare Biotechnology

Patrys Limited is an Australia-based company, which is focused on the development of its... Patrys Limited is an Australia-based company, which is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company's deoxymab platform is based on the deoxymab 3E10 antibody that was identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus. It has developed two humanized forms of deoxymab 3E10, both of which have improved activity over the original deoxymab 3E10 antibody: PAT-DX1, which is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, and PAT-DX3, which is a full-sized Immunoglobulin G antibody. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. Its PAT-DX1- nanoparticles (NP) pipeline involves using its PAT-DX1 to develop a new drug based on the targeted delivery of NP carrying therapeutic payloads to the inside of cancer cells.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PAB	Collaborations Support PAT-SM6 Clinical Program	PRICE SENSITIVE	20/06/11	377.61KB	Share
PAB	New CEO Investor Presentation		02/06/11	1.41MB	Share
PAB	Patrys Confirms Clinical Status - Appoints New CEO	PRICE SENSITIVE	26/05/11	311.2KB	Share
PAB	Agreement for PAT-LM1 Production Keeps Development on Track	PRICE SENSITIVE	13/05/11	370.84KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - March 2011	PRICE SENSITIVE	19/04/11	109.21KB	Share
PAB	Patrys Patents Allowed in Major Markets	PRICE SENSITIVE	13/04/11	343.42KB	Share
PAB	Becoming a substantial holder		22/03/11	58.71KB	Share
PAB	Patrys Receives Company of the Year Award		17/03/11	296.2KB	Share
PAB	Patrys Elects Closure of Finance Facility		11/03/11	673.11KB	Share
PAB	International Investor Update Presentation		09/03/11	1.85MB	Share
PAB	Advances for Gastric Cancer Program	PRICE SENSITIVE	09/03/11	418.66KB	Share
PAB	Ceasing to be a substantial holder		09/03/11	211.39KB	Share
PAB	Change in substantial holding		09/03/11	285.65KB	Share
PAB	Biotech Industry's Interest in PAT-SM6 Target Growing	PRICE SENSITIVE	08/03/11	375.5KB	Share
PAB	Change of Director's Interest Notice		08/03/11	222.23KB	Share
PAB	Half Yearly Report - December 2010	PRICE SENSITIVE	23/02/11	574.55KB	Share
PAB	Section 708A - Cleansing Statement		18/02/11	259.97KB	Share
PAB	Appendix 3B		18/02/11	131.4KB	Share
PAB	Section 708A - Cleansing Statement		28/01/11	427.94KB	Share
PAB	Appendix 3B		28/01/11	131.35KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - December 2010	PRICE SENSITIVE	18/01/11	109.23KB	Share
PAB	Issue of Securities		13/01/11	316.48KB	Share
PAB	Change in substantial holding		31/12/10	131.28KB	Share
PAB	Section 708A - Cleansing Statement		30/12/10	262.4KB	Share
PAB	Appendix 3B		30/12/10	135.11KB	Share
PAB	Change of Director's Interest Notice		30/12/10	112.99KB	Share
PAB	Securities Trading Policy		21/12/10	102.02KB	Share
PAB	Patent Filed to Protect Proprietary Manufacturing Technology	PRICE SENSITIVE	20/12/10	357.36KB	Share
PAB	Patrys Receives Approval to Progress Melanoma Clinical Trial	PRICE SENSITIVE	15/12/10	318.94KB	Share
PAB	Change of Director's Interest Notice		14/12/10	111.19KB	Share
PAB	Change of Director's Interest Notice		14/12/10	112.85KB	Share
PAB	Appendix 3B - Share Purchase Plan		14/12/10	133.92KB	Share
PAB	Patrys Completes Capital Raising		14/12/10	261.02KB	Share
PAB	Section 708A - Cleansing Statement		01/12/10	259.72KB	Share
PAB	Section 708A - Cleansing Statement		26/11/10	259.55KB	Share
PAB	Appendix 3B		26/11/10	133.96KB	Share
PAB	New Grants to Support Patrys' Product Development	PRICE SENSITIVE	25/11/10	346.44KB	Share
PAB	Patrys Funding Update	PRICE SENSITIVE	24/11/10	257.58KB	Share
PAB	Patrys Share Purchase Plan opens - 22 November 2010		22/11/10	248.61KB	Share
PAB	Capital Raising - Notice of EGM 22 December 2010 and Proxy		22/11/10	505.76KB	Share
PAB	Patrys Announces Update to Capital Raising		18/11/10	260.37KB	Share
PAB	Patrys Announces Capital Raising of $3.2 Million and SPP	PRICE SENSITIVE	17/11/10	342.99KB	Share
PAB	Trading Halt	PRICE SENSITIVE	15/11/10	101.78KB	Share
PAB	Patrys CEO Presents at Wilson HTM Life Sciences Conference		11/11/10	1.08MB	Share
PAB	Treatment of First Group of Melanoma Patients Completed	PRICE SENSITIVE	10/11/10	336.75KB	Share
PAB	PAT-SC1 Orphan Status Granted by U.S. FDA	PRICE SENSITIVE	05/11/10	302.1KB	Share
PAB	Change of Director's Interest Notice		29/10/10	111.78KB	Share
PAB	Appendix 3B		29/10/10	214.07KB	Share
PAB	Appendix 4C - Quarterly Cash Flow	PRICE SENSITIVE	29/10/10	108.92KB	Share
PAB	Replacement Appendix 3F - Loan Share Plan Buy Back		29/10/10	335.82KB	Share
PAB	Replacement Appendix 3E - Loan Share Plan Buy Back		29/10/10	313.62KB	Share
PAB	Amended Constitution - 29 October 2010		29/10/10	557.85KB	Share
PAB	Results of Meeting - 2010 AGM		29/10/10	393.73KB	Share
PAB	CEO's Presentation to AGM 2010		29/10/10	869.21KB	Share
PAB	Patrys Investor Activity Update		22/10/10	93.18KB	Share
PAB	Groundbreaking PAT-SM6 Melanoma Clinical Trial Initiated	PRICE SENSITIVE	19/10/10	325.73KB	Share
PAB	Patrys CEO Presentation		15/10/10	869.24KB	Share
PAB	Notice of Annual General Meeting/Proxy Form		28/09/10	327.41KB	Share
PAB	Copy of ASIC Form 484 - Loan Share Plan Buy Back		28/09/10	25.66KB	Share
PAB	Appendix 3F - Loan Share Plan Buy Back		28/09/10	336.04KB	Share
PAB	Appendix 3E - Loan Share Plan Buy Back		28/09/10	313.91KB	Share
PAB	Appendix 3C - Loan Share Plan Buy Back		27/09/10	328.12KB	Share
PAB	Section 708A - Cleansing Statement		21/09/10	257.17KB	Share
PAB	Appendix 3B		21/09/10	130.75KB	Share
PAB	Patrys 2010 Annual Report		30/08/10	1.1MB	Share
PAB	Appendix 4E and 2010 Annual Report	PRICE SENSITIVE	30/08/10	1.32MB	Share
PAB	Patrys Newsletter - August 2010		26/08/10	1.02MB	Share
PAB	Section 708A - Cleansing Statement		18/08/10	259.65KB	Share
PAB	Appendix 3B		18/08/10	132.9KB	Share
PAB	Issue of Securities		17/08/10	264.6KB	Share
PAB	Patrys Expands Executive Management Team		12/08/10	282.9KB	Share
PAB	Appendix 3B - AOF Funding		03/08/10	133.83KB	Share
PAB	Section 708A - Cleansing Statement		03/08/10	251.17KB	Share
PAB	Patrys Secures Funding of up to A$15 Million	PRICE SENSITIVE	03/08/10	367.74KB	Share
PAB	Copy of ASIC Form 484 - Loan Share Plan Buy Back		02/08/10	25.32KB	Share
PAB	Appendix 3F - Loan Share Plan Buy Back		02/08/10	334.14KB	Share
PAB	Patrys' PAT-SM6 Melanoma Human Trial Approved	PRICE SENSITIVE	02/08/10	341.37KB	Share
PAB	Appendix 3E - Loan Share Plan Buy Back		02/08/10	309.78KB	Share
PAB	Appendix 3C - Loan Share Plan Buy Back		30/07/10	328.19KB	Share
PAB	Patrys Acquires Promising Therapeutic Candidate	PRICE SENSITIVE	28/07/10	270.34KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - June 2010	PRICE SENSITIVE	22/07/10	105.4KB	Share
PAB	Patrys Granted Key U.S. Patent on Lead Product	PRICE SENSITIVE	06/07/10	332.18KB	Share
PAB	Appendix 3B		01/07/10	137.24KB	Share
PAB	Patrys Expands Product Pipeline	PRICE SENSITIVE	18/06/10	351.03KB	Share
CSL +PAB	Patrys Reaches First Milestone in CSL Collaboration	PRICE SENSITIVE	28/05/10	192.44KB	Share
PAB	Patrys PAT-SM6 Clinical Trial Update	PRICE SENSITIVE	24/05/10	315.33KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - March 2010	PRICE SENSITIVE	19/04/10	108.61KB	Share
PAB	Patrys Activity Update/Newsletter - March 2010		25/03/10	1.82MB	Share
PAB	Half Yearly Report - December 2009	PRICE SENSITIVE	26/02/10	362.3KB	Share
PAB	Patrys Granted Key Patent	PRICE SENSITIVE	24/02/10	325.02KB	Share
CSL +PAB	Patrys - CSL Collaboration	PRICE SENSITIVE	28/01/10	79.32KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - December 2009	PRICE SENSITIVE	27/01/10	58.76KB	Share
PAB	Appendix 3B		02/12/09	93.42KB	Share
PAB	Change of Director's Interest Notice		02/12/09	39.26KB	Share
PAB	Change of Director's Interest Notice		02/12/09	39.01KB	Share
PAB	Change of Director's Interest Notice		02/12/09	40.36KB	Share
PAB	Appendix 3B		02/12/09	63.02KB	Share
PAB	Release of Shares from Voluntary Escrow		01/12/09	40.62KB	Share
PAB	Results of Meeting - 2009 AGM		27/11/09	87.49KB	Share
PAB	CEO's Presentation to AGM 2009		27/11/09	881.23KB	Share

PABCollaborations Support PAT-SM6 Clinical Program
20/06/11	PRICE SENSITIVE	377.61KB	Share
PABNew CEO Investor Presentation
02/06/11		1.41MB	Share
PABPatrys Confirms Clinical Status - Appoints New CEO
26/05/11	PRICE SENSITIVE	311.2KB	Share
PABAgreement for PAT-LM1 Production Keeps Development on Track
13/05/11	PRICE SENSITIVE	370.84KB	Share
PABAppendix 4C - Quarterly Cash Flow - March 2011
19/04/11	PRICE SENSITIVE	109.21KB	Share
PABPatrys Patents Allowed in Major Markets
13/04/11	PRICE SENSITIVE	343.42KB	Share
PABBecoming a substantial holder
22/03/11		58.71KB	Share
PABPatrys Receives Company of the Year Award
17/03/11		296.2KB	Share
PABPatrys Elects Closure of Finance Facility
11/03/11		673.11KB	Share
PABInternational Investor Update Presentation
09/03/11		1.85MB	Share
PABAdvances for Gastric Cancer Program
09/03/11	PRICE SENSITIVE	418.66KB	Share
PABCeasing to be a substantial holder
09/03/11		211.39KB	Share
PABChange in substantial holding
09/03/11		285.65KB	Share
PABBiotech Industry's Interest in PAT-SM6 Target Growing
08/03/11	PRICE SENSITIVE	375.5KB	Share
PABChange of Director's Interest Notice
08/03/11		222.23KB	Share
PABHalf Yearly Report - December 2010
23/02/11	PRICE SENSITIVE	574.55KB	Share
PABSection 708A - Cleansing Statement
18/02/11		259.97KB	Share
PABAppendix 3B
18/02/11		131.4KB	Share
PABSection 708A - Cleansing Statement
28/01/11		427.94KB	Share
PABAppendix 3B
28/01/11		131.35KB	Share
PABAppendix 4C - Quarterly Cash Flow - December 2010
18/01/11	PRICE SENSITIVE	109.23KB	Share
PABIssue of Securities
13/01/11		316.48KB	Share
PABChange in substantial holding
31/12/10		131.28KB	Share
PABSection 708A - Cleansing Statement
30/12/10		262.4KB	Share
PABAppendix 3B
30/12/10		135.11KB	Share
PABChange of Director's Interest Notice
30/12/10		112.99KB	Share
PABSecurities Trading Policy
21/12/10		102.02KB	Share
PABPatent Filed to Protect Proprietary Manufacturing Technology
20/12/10	PRICE SENSITIVE	357.36KB	Share
PABPatrys Receives Approval to Progress Melanoma Clinical Trial
15/12/10	PRICE SENSITIVE	318.94KB	Share
PABChange of Director's Interest Notice
14/12/10		111.19KB	Share
PABChange of Director's Interest Notice
14/12/10		112.85KB	Share
PABAppendix 3B - Share Purchase Plan
14/12/10		133.92KB	Share
PABPatrys Completes Capital Raising
14/12/10		261.02KB	Share
PABSection 708A - Cleansing Statement
01/12/10		259.72KB	Share
PABSection 708A - Cleansing Statement
26/11/10		259.55KB	Share
PABAppendix 3B
26/11/10		133.96KB	Share
PABNew Grants to Support Patrys' Product Development
25/11/10	PRICE SENSITIVE	346.44KB	Share
PABPatrys Funding Update
24/11/10	PRICE SENSITIVE	257.58KB	Share
PABPatrys Share Purchase Plan opens - 22 November 2010
22/11/10		248.61KB	Share
PABCapital Raising - Notice of EGM 22 December 2010 and Proxy
22/11/10		505.76KB	Share
PABPatrys Announces Update to Capital Raising
18/11/10		260.37KB	Share
PABPatrys Announces Capital Raising of $3.2 Million and SPP
17/11/10	PRICE SENSITIVE	342.99KB	Share
PABTrading Halt
15/11/10	PRICE SENSITIVE	101.78KB	Share
PABPatrys CEO Presents at Wilson HTM Life Sciences Conference
11/11/10		1.08MB	Share
PABTreatment of First Group of Melanoma Patients Completed
10/11/10	PRICE SENSITIVE	336.75KB	Share
PABPAT-SC1 Orphan Status Granted by U.S. FDA
05/11/10	PRICE SENSITIVE	302.1KB	Share
PABChange of Director's Interest Notice
29/10/10		111.78KB	Share
PABAppendix 3B
29/10/10		214.07KB	Share
PABAppendix 4C - Quarterly Cash Flow
29/10/10	PRICE SENSITIVE	108.92KB	Share
PABReplacement Appendix 3F - Loan Share Plan Buy Back
29/10/10		335.82KB	Share
PABReplacement Appendix 3E - Loan Share Plan Buy Back
29/10/10		313.62KB	Share
PABAmended Constitution - 29 October 2010
29/10/10		557.85KB	Share
PABResults of Meeting - 2010 AGM
29/10/10		393.73KB	Share
PABCEO's Presentation to AGM 2010
29/10/10		869.21KB	Share
PABPatrys Investor Activity Update
22/10/10		93.18KB	Share
PABGroundbreaking PAT-SM6 Melanoma Clinical Trial Initiated
19/10/10	PRICE SENSITIVE	325.73KB	Share
PABPatrys CEO Presentation
15/10/10		869.24KB	Share
PABNotice of Annual General Meeting/Proxy Form
28/09/10		327.41KB	Share
PABCopy of ASIC Form 484 - Loan Share Plan Buy Back
28/09/10		25.66KB	Share
PABAppendix 3F - Loan Share Plan Buy Back
28/09/10		336.04KB	Share
PABAppendix 3E - Loan Share Plan Buy Back
28/09/10		313.91KB	Share
PABAppendix 3C - Loan Share Plan Buy Back
27/09/10		328.12KB	Share
PABSection 708A - Cleansing Statement
21/09/10		257.17KB	Share
PABAppendix 3B
21/09/10		130.75KB	Share
PABPatrys 2010 Annual Report
30/08/10		1.1MB	Share
PABAppendix 4E and 2010 Annual Report
30/08/10	PRICE SENSITIVE	1.32MB	Share
PABPatrys Newsletter - August 2010
26/08/10		1.02MB	Share
PABSection 708A - Cleansing Statement
18/08/10		259.65KB	Share
PABAppendix 3B
18/08/10		132.9KB	Share
PABIssue of Securities
17/08/10		264.6KB	Share
PABPatrys Expands Executive Management Team
12/08/10		282.9KB	Share
PABAppendix 3B - AOF Funding
03/08/10		133.83KB	Share
PABSection 708A - Cleansing Statement
03/08/10		251.17KB	Share
PABPatrys Secures Funding of up to A$15 Million
03/08/10	PRICE SENSITIVE	367.74KB	Share
PABCopy of ASIC Form 484 - Loan Share Plan Buy Back
02/08/10		25.32KB	Share
PABAppendix 3F - Loan Share Plan Buy Back
02/08/10		334.14KB	Share
PABPatrys' PAT-SM6 Melanoma Human Trial Approved
02/08/10	PRICE SENSITIVE	341.37KB	Share
PABAppendix 3E - Loan Share Plan Buy Back
02/08/10		309.78KB	Share
PABAppendix 3C - Loan Share Plan Buy Back
30/07/10		328.19KB	Share
PABPatrys Acquires Promising Therapeutic Candidate
28/07/10	PRICE SENSITIVE	270.34KB	Share
PABAppendix 4C - Quarterly Cash Flow - June 2010
22/07/10	PRICE SENSITIVE	105.4KB	Share
PABPatrys Granted Key U.S. Patent on Lead Product
06/07/10	PRICE SENSITIVE	332.18KB	Share
PABAppendix 3B
01/07/10		137.24KB	Share
PABPatrys Expands Product Pipeline
18/06/10	PRICE SENSITIVE	351.03KB	Share
CSL +PABPatrys Reaches First Milestone in CSL Collaboration
28/05/10	PRICE SENSITIVE	192.44KB	Share
PABPatrys PAT-SM6 Clinical Trial Update
24/05/10	PRICE SENSITIVE	315.33KB	Share
PABAppendix 4C - Quarterly Cash Flow - March 2010
19/04/10	PRICE SENSITIVE	108.61KB	Share
PABPatrys Activity Update/Newsletter - March 2010
25/03/10		1.82MB	Share
PABHalf Yearly Report - December 2009
26/02/10	PRICE SENSITIVE	362.3KB	Share
PABPatrys Granted Key Patent
24/02/10	PRICE SENSITIVE	325.02KB	Share
CSL +PABPatrys - CSL Collaboration
28/01/10	PRICE SENSITIVE	79.32KB	Share
PABAppendix 4C - Quarterly Cash Flow - December 2009
27/01/10	PRICE SENSITIVE	58.76KB	Share
PABAppendix 3B
02/12/09		93.42KB	Share
PABChange of Director's Interest Notice
02/12/09		39.26KB	Share
PABChange of Director's Interest Notice
02/12/09		39.01KB	Share
PABChange of Director's Interest Notice
02/12/09		40.36KB	Share
PABAppendix 3B
02/12/09		63.02KB	Share
PABRelease of Shares from Voluntary Escrow
01/12/09		40.62KB	Share
PABResults of Meeting - 2009 AGM
27/11/09		87.49KB	Share
PABCEO's Presentation to AGM 2009
27/11/09		881.23KB	Share

REFRESH

First 3 4 5 6 7

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $16.46M

Open	High	Low	Value	Volume
0.8¢	0.8¢	0.8¢	$9.792K	1.223M

Buyers (Bids)

No.	Vol.	Price($)
21	5859941	0.7¢

Sellers (Offers)

Price($)	Vol.	No.
0.8¢	128118	2

View Market Depth

No.	Vol.	Price($)
21	5859941	0.007
9	2237680	0.006
8	3155992	0.005
5	4324000	0.004
3	2029016	0.003

Price($)	Vol.	No.
0.008	128118	2
0.009	1660014	3
0.010	1400000	2
0.011	1260000	4
0.012	372407	3

Last trade - 14.51pm 10/05/2024 (20 minute delay)


Last 0.8¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
0.7¢	0.8¢	0.7¢	150544
Last updated 14.09pm 10/05/2024 ?

PAB (ASX) Chart

PATRYS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available